Detalles de la búsqueda
1.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560813
2.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199127
3.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer
; 127(12): 2003-2014, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626197
4.
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
Br J Haematol
; 189(4): 672-683, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32068246
5.
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia.
Haematologica
; 104(2): 288-296, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30093399
6.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057357
7.
Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes.
Eur J Haematol
; 101(3): 332-339, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846964
8.
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
Br J Haematol
; 190(1): e16-e20, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32379921
9.
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.
Haematologica
; 100(10): 1294-300, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26160880
10.
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
Ann Hematol
; 94(8): 1357-61, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25911134
11.
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
Ann Hematol
; 93(1): 43-6, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081577
12.
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254867
13.
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study.
Lancet Haematol
; 10(11): e902-e912, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914483
14.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Cancers (Basel)
; 15(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900296
15.
Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
Nephrol Dial Transplant
; 27(7): 2720-33, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22302208
16.
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.
Transplant Cell Ther
; 28(5): 258.e1-258.e8, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131486
17.
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.
Cancers (Basel)
; 14(22)2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428762
18.
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience.
Cancers (Basel)
; 14(11)2022 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681653
19.
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
Front Oncol
; 12: 1054458, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36505804
20.
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Transplant Cell Ther
; 28(4): 204.e1-204.e10, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108627